Clinical Trials in San Francisco

Showing 2521-2540 of 11,161 trials

COMPLETEDNA< 1 mile

EMPOWER AUD Pivotal Trial

NCT05948605

Multi-site, double-blinded, prospective, randomized, sham-controlled study

AlcoholismAlcohol AbuseAlcohol Use Disorder

Theranova, L.L.C.35 participantsStarted Dec 2023

San Francisco, California, United States • New Haven, Connecticut, United States

TERMINATEDPhase 1< 1 mile

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

NCT02900651

The purpose of this Phase I/II study is to establish the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) and to evaluate the safety, antitumor activity and pharmacokinetic (PK) profile of MAK683 in patients with advanced malignancies such as Diffuse Large B cell Lymphoma (DLBCL), nasopharyngeal carcinoma (NPC) or other advanced solid tumors for whom no further effective standard treatment is available.

Diffuse Large B-cell Lymphoma

Novartis Pharmaceuticals139 participantsStarted Oct 2016

San Francisco, California, United States • Santa Monica, California, United States • Houston, Texas, United States +13 more locations

EMPOWER AUD Pivotal Trial

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

Find Trials by Condition in San Francisco

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

Hemodynamic-GUIDEd Management of Heart Failure

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes